Log In
Print
BCIQ
Print
Print this Print this
 

Previstage GCC Colorectal Cancer Staging Test

  Manage Alerts
Collapse Summary General Information
Company DiagnoCure Inc.
DescriptionGuanylate cyclase C (GCC; GUCY2C) lymph node test that uses qRT-PCR technology for staging of colorectal cancer
Molecular Target Guanylate cyclase C (GCC) (GUCY2C)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose colorectal cancer; Predict risk of colon cancer recurrence
Regulatory Designation

Partner

Shuwen Biotech Co. Ltd.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$13.3M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today